Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

ConditionLocally Advanced Cervical Carcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

To evaluate the degree of acute and long-term intestinal, urinary and vaginal toxicity, and the impact on sexual activity of an accelerated fractionation of high dose rate interventional radiotherapy (IRT-HDR) in patients with locally advanced cervical cancer (IB2 - VA, N+/-).

Eligibility criteria

Qualifiers

Age ≥18 years

ECOG 0-2

Histological diagnosis of squamous carcinoma and/or adenocarcinoma of the uterine cervix

FIGO IB2 Stadium - IVA (staging 20018)

Disqualifiers

Age <18 years

PS >2

Previous cancer in the last 10 years

Previous radiation treatment in the region of interest

Trial design

Treatments tested in this trial

Interventional Radiotherapy

Treatment groups

No treatment groups listed

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor

Source ClinicalTrials.gov